Cloud LAB Act of 2026
- Bill Number
- H.R. 7801
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Science, Technology, Communications
- Status
- Introduced
- Latest Action
- 2026-03-04: Referred to the House Committee on Science, Space, and Technology.
- Last Updated
- 2026-04-02T18:04:39Z
AI-Generated Summary
Purpose of the Legislation
The Cloud Labs to Advance Biotechnology Act of 2026 (Cloud LAB Act) aims to boost biotechnology research by creating a national network of "cloud laboratories." These are physical labs equipped with robots and instruments that scientists can control remotely to run experiments and collect data. The goal is to generate high-quality biological data (information from living systems like cells or organisms) for training artificial intelligence (AI) models and supporting individual research projects, while connecting existing labs for better collaboration.
Key Provisions
- Definitions: Clarifies terms like "cloud laboratory" (a remote-controlled lab for automated experiments), "biological data" (info from biological structures or processes), "authorized researcher" (approved users who can access data), and references the definition of AI from existing law.
- Pilot Program Establishment (Phase I):
- NSF Director, in consultation with the Department of Energy (DOE) Secretary and NIST Director, must establish the network within 360 days of enactment.
- Network tracks biotech capabilities across labs (public and private), helps researchers find needed tools, and promotes collaboration on data standards and sharing.
- Requires an implementation plan submitted to Congress within 360 days, covering assessments of current labs, data storage and access (publicly available securely), payment models (free or low-cost for non-proprietary work), intellectual property agreements, industry engagement, and security plans (cyber, bio, research).
- Creates a Cloud Laboratory Advisory Board (led by NSF) with experts from government, academia, industry, and ethics fields. The board advises on data priorities, lab development, researcher access, and safeguards; it terminates after 12 years.
- Grant Awards for New Labs:
- Phase II: Competitive grants for at least 2 cloud labs within 2 years; labs must be operational in 3 years; 8-year funding period.
- Phase III: Additional competitive grants for at least 3 more labs within 4 years; 6-year funding; builds on Phase II lessons.
- Awards focus on biotech, with consultations including the Executive Office of the President for biotech coordination.
- Reporting and Sunset: Annual progress reports to Congress starting 1 year after Phase II awards; entire pilot ends after 12 years.
Significant Changes to Existing Law
This bill introduces a new pilot program at the National Science Foundation (NSF) without directly amending prior laws. It builds on existing definitions (e.g., AI from a 2021 defense act) but creates fresh requirements for NSF to fund and network cloud labs, coordinate with agencies like DOE and NIST, and establish advisory and data-sharing mechanisms. No existing programs are altered, but it mandates deduplication of efforts to avoid overlap with other federal biotech initiatives.
Potential Impacts
- Government Agencies: NSF leads with new responsibilities for grants, planning, and reporting; increases coordination with DOE (energy/tech support), NIST (standards/tech), and White House biotech offices. Could strain budgets without specified funding, relying on appropriations.
- Citizens and Researchers: Enhances access to advanced lab tools and data for academics, students, and non-profits at low/no cost, potentially speeding up biotech discoveries in health, agriculture, and chemicals. Public data access could democratize research but requires secure handling to protect privacy.
- International Relations: Minimal direct impact, but bolstering U.S. biotech infrastructure could strengthen global competitiveness in AI-driven science; security plans address risks like foreign misuse of data.
Main Stakeholders Affected
- Government: NSF (primary implementer), DOE, NIST, and Executive Office of the President (coordination and oversight).
- Researchers and Academia: Authorized scientists, universities, and teaching institutions gain remote access to labs and data for AI training and projects.
- Industry: Biotech companies (health, agriculture, chemicals) can join the network, subscribe to services, and collaborate, with tailored intellectual property options.
- Ethics and Security Experts: Involved via advisory board to ensure safe, ethical use.
- General Public: Indirect benefits through faster biotech innovations, though access is limited to authorized users.
Notable Legal, Constitutional, or Political Implications
- Legal: Emphasizes competitive grants and public data access, aligning with federal open-science policies; requires robust cybersecurity and biosecurity (protection against biological risks) from the start, potentially setting precedents for AI-biotech integration. Intellectual property schemes allow flexibility but must balance public benefit with private innovation.
- Constitutional: Supports the government's role in promoting science and useful arts (Article I, Section 8), without raising free speech or privacy concerns if data safeguards are implemented.
- Political: Bipartisan introduction (by Reps. Obernolte, Khanna, Auchincloss, McCormick) signals broad support for U.S. biotech leadership amid global AI competition. The 12-year sunset provides a temporary framework for evaluation, but reliance on appropriations could face partisan budget debates; advisory board inclusion of diverse voices promotes inclusive policymaking.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (4)
Rep. Khanna, Ro [D-CA-17], Rep. Auchincloss, Jake [D-MA-4], Rep. McCormick, Richard [R-GA-7], Rep. Houlahan, Chrissy [D-PA-6]
Recent Actions
- 2026-03-04: Referred to the House Committee on Science, Space, and Technology.
- 2026-03-04: Introduced in House
- 2026-03-04: Introduced in House
Bill Versions
- Cloud Labs to Advance Biotechnology Act of 2026 — issued 2026-03-04 — PDF (12 pages)